BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8051150)

  • 21. Localization of a factor X interactive site in the A1 subunit of factor VIIIa.
    Lapan KA; Fay PJ
    J Biol Chem; 1997 Jan; 272(4):2082-8. PubMed ID: 8999906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa.
    Fay PJ; Smudzin TM
    J Biol Chem; 1992 Jul; 267(19):13246-50. PubMed ID: 1618828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA.
    Fay PJ; Mastri M; Koszelak ME; Wakabayashi H
    J Biol Chem; 2001 Apr; 276(15):12434-9. PubMed ID: 11278520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosite binding drives substrate affinity for the activation of coagulation factor X by the intrinsic Xase complex.
    Basavaraj MG; Krishnaswamy S
    J Biol Chem; 2020 Nov; 295(45):15198-15207. PubMed ID: 32859749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis.
    Fay PJ; Beattie TL; Regan LM; O'Brien LM; Kaufman RJ
    J Biol Chem; 1996 Mar; 271(11):6027-32. PubMed ID: 8626386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sites in the A2 subunit involved in the interfactor VIIIa interaction.
    Koszelak ME; Huggins CF; Fay PJ
    J Biol Chem; 2000 Sep; 275(35):27137-44. PubMed ID: 10831590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXa.
    Fay PJ; Scandella D
    J Biol Chem; 1999 Oct; 274(42):29826-30. PubMed ID: 10514461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of a pH-dependent, A2 subunit-interactive surface within the factor VIIIa A1 subunit.
    Nogami K; Wakabayashi H; Ansong C; Fay PJ
    Biochim Biophys Acta; 2004 Sep; 1701(1-2):25-35. PubMed ID: 15450173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa.
    Griffiths AE; Rydkin I; Fay PJ
    J Biol Chem; 2013 May; 288(21):15057-64. PubMed ID: 23580639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit.
    Fay PJ; Haidaris PJ; Smudzin TM
    J Biol Chem; 1991 May; 266(14):8957-62. PubMed ID: 1902833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa.
    Bajaj SP; Schmidt AE; Mathur A; Padmanabhan K; Zhong D; Mastri M; Fay PJ
    J Biol Chem; 2001 May; 276(19):16302-9. PubMed ID: 11278963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
    Fang H; Zögg T; Brandstetter H
    FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gla domain of factor IXa binds to factor VIIIa in the tenase complex.
    Blostein MD; Furie BC; Rajotte I; Furie B
    J Biol Chem; 2003 Aug; 278(33):31297-302. PubMed ID: 12782629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.
    Wakabayashi H; Fay PJ
    J Biol Chem; 2008 Apr; 283(17):11645-51. PubMed ID: 18299331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36.
    Nogami K; Nishiya K; Saenko EL; Takeyama M; Ogiwara K; Yoshioka A; Shima M
    J Biol Chem; 2009 Mar; 284(11):6934-45. PubMed ID: 19126539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of factor Xa-catalyzed cleavage of the factor VIIIa A1 subunit resulting in cofactor inactivation.
    Nogami K; Wakabayashi H; Fay PJ
    J Biol Chem; 2003 May; 278(19):16502-9. PubMed ID: 12606556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.